TONIX PHARMACEUTICALS HOLDING CORP. Earnings Per Share (Basic)
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Earnings Per Share (Basic) of -$2.44 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. earnings per share, basic for the quarter ending 2026-06-30 was -$2.44.
- TONIX PHARMACEUTICALS HOLDING CORP. earnings per share, basic for the quarter ending 2026-03-31 was -$2.93.
- TONIX PHARMACEUTICALS HOLDING CORP. earnings per share, basic for the quarter ending 2025-12-31 was -$3.96.
- TONIX PHARMACEUTICALS HOLDING CORP. earnings per share, basic for the quarter ending 2025-09-30 was -$3.59.
- TONIX PHARMACEUTICALS HOLDING CORP. earnings per share, basic for fiscal 2025 was -$14.57.
- TONIX PHARMACEUTICALS HOLDING CORP. earnings per share, basic for fiscal 2024 was -$176.60.
- TONIX PHARMACEUTICALS HOLDING CORP. earnings per share, basic for fiscal 2023 was -$14720.25.
- TONIX PHARMACEUTICALS HOLDING CORP. earnings per share, basic for fiscal 2022 was -$20.01.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.44 10-Q · filed 2026-08-10 | -$5.32 10-Q · filed 2026-08-10 | -$9.08 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$12.50 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2026-03-31 | -$2.93 10-Q · filed 2026-05-11 | -$6.82 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$10.37 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$14.11 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-12-31 | -$3.96 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$7.60 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$11.45 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$14.57 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$3.59 10-Q · filed 2025-11-10 | -$7.42 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$10.42 10-Q · filed 2025-11-10 | -$16.25 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-06-30 | -$3.86 10-Q · filed 2026-08-10 | -$6.80 10-Q · filed 2026-08-10 | -$13.00 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$20.19 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-03-31 | -$2.84 10-Q · filed 2026-05-11 | -$9.52 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$18.11 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$59.66 derived: net income ÷ weighted average shares · filed 2026-05-11 | ||||
| 2024-12-31 | -$9.82 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$25.25 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$118.31 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$176.60 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$22.68 10-Q · filed 2025-11-10 | -$0.23 10-Q · filed 2024-11-12 | -$278.54 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$466.17 10-Q · filed 2025-11-10 | -$4.66 10-Q · filed 2024-11-12 | $474.23 derived: net income ÷ weighted average shares · filed 2025-11-10 | ||
| 2024-06-30 | -$1920.85 10-Q · filed 2025-08-11 | -$19.28 10-Q · filed 2024-08-16 | -$2720.40 10-Q · filed 2025-08-11 | -$27.33 10-Q · filed 2024-08-16 | $205.44 derived: net income ÷ weighted average shares · filed 2025-08-11 | $571.33 derived: net income ÷ weighted average shares · filed 2025-08-11 | ||
| 2024-03-31 | -$535.72 10-Q · filed 2025-05-12 | -$0.18 10-Q · filed 2024-05-13 | $46.74 derived: net income ÷ weighted average shares · filed 2025-05-12 | $194.33 derived: net income ÷ weighted average shares · filed 2025-05-12 | $775.97 derived: net income ÷ weighted average shares · filed 2025-05-12 | |||
| 2023-12-31 | $14.88 derived: net income ÷ weighted average shares · filed 2025-03-18 | $99.44 derived: net income ÷ weighted average shares · filed 2025-03-18 | $468.11 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$14720.25 10-K · filed 2025-03-18 | -$6.85 10-K · filed 2024-04-01 | |||
| 2023-09-30 | -$38.63 10-Q · filed 2024-11-12 | -$1.83 10-Q · filed 2023-11-09 | -$86.65 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$143.47 10-Q · filed 2024-11-12 | -$7.40 10-Q · filed 2023-11-09 | -$22.89 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-06-30 | -$49.23 10-Q · filed 2024-08-16 | -$2.68 10-Q · filed 2023-08-10 | -$107.45 10-Q · filed 2024-08-16 | -$5.88 10-Q · filed 2023-08-10 | -$13.74 derived: net income ÷ weighted average shares · filed 2024-08-16 | -$17.98 derived: net income ÷ weighted average shares · filed 2024-08-16 | ||
| 2023-03-31 | -$3.21 10-Q · filed 2024-05-13 | -$0.52 10-Q · filed 2023-05-08 | -$6.62 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$10.63 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$16.09 derived: net income ÷ weighted average shares · filed 2024-05-13 | |||
| 2022-12-31 | -$3.41 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$7.49 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$13.29 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$20.01 10-K · filed 2024-04-01 | -$3.27 10-K · filed 2023-03-13 | |||
| 2022-09-30 | -$4.24 10-Q · filed 2023-11-09 | -$0.69 10-Q · filed 2022-11-07 | -$10.81 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$18.58 10-Q · filed 2023-11-09 | -$3.06 10-Q · filed 2022-11-07 | |||
| 2022-06-30 | -$7.64 10-Q · filed 2023-08-10 | -$1.22 10-Q · filed 2022-08-08 | -$17.28 10-Q · filed 2023-08-10 | -$2.76 10-Q · filed 2022-08-08 | ||||
| 2022-03-31 | -$1.61 10-Q · filed 2023-05-08 | -$0.05 10-Q · filed 2022-05-09 | ||||||
| 2021-12-31 | -$2.07 derived: net income ÷ weighted average shares · filed 2023-03-13 | -$3.72 derived: net income ÷ weighted average shares · filed 2023-03-13 | -$5.92 derived: net income ÷ weighted average shares · filed 2023-03-13 | -$8.10 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | -$1.60 10-Q · filed 2022-11-07 | -$3.81 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$6.02 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | -$2.25 10-Q · filed 2022-08-08 | -$4.49 10-Q · filed 2022-08-08 | ||||||
| 2021-03-31 | -$0.07 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |